Position in RVMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$194,715,388
+$41,080,520 QoQ
Shares Held
1,039,702
-34.2% QoQ
Ownership
0.485%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#39
of 685 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 97%
None 3%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names. RVMD ranks #4 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
This page
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in RVMD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $194,715,388 | 1,039,702 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $153,634,868 | 1,579,793 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $163,828,657 | 2,056,857 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $57,196,242 | 1,224,759 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $49,462,680 | 1,344,460 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $52,709,665 | 1,490,658 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $71,158,328 | 1,626,848 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $67,363,883 | 1,485,422 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $57,139,572 | 1,472,290 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $54,613,764 | 1,694,501 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $46,548,241 | 1,623,021 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $33,544,173 | 1,211,856 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $32,734,643 | 1,223,725 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $24,344,929 | 1,123,958 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $16,695,984 | 700,923 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $19,583,201 | 993,063 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $19,515,491 | 1,001,308 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $24,757,810 | 970,514 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $24,195,818 | 961,296 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $26,388,334 | 959,227 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $29,755,772 | 937,485 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $19,269,920 | 420,007 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $10,741,755 | 271,325 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,748,316 | 50,239 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,403,097 | 44,444 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,392,051 | 63,535 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||